Titlebook: Viral Hepatitis: Chronic Hepatitis C; Resat Ozaras,Dominique Salmon-Ceron Book 2019 Springer Nature Switzerland AG 2019 infectious disease

短暫

書目名稱Viral Hepatitis: Chronic Hepatitis C影響因子(影響力)




書目名稱Viral Hepatitis: Chronic Hepatitis C影響因子(影響力)學科排名




書目名稱Viral Hepatitis: Chronic Hepatitis C網(wǎng)絡(luò)公開度




書目名稱Viral Hepatitis: Chronic Hepatitis C網(wǎng)絡(luò)公開度學科排名




書目名稱Viral Hepatitis: Chronic Hepatitis C被引頻次




書目名稱Viral Hepatitis: Chronic Hepatitis C被引頻次學科排名




書目名稱Viral Hepatitis: Chronic Hepatitis C年度引用




書目名稱Viral Hepatitis: Chronic Hepatitis C年度引用學科排名




書目名稱Viral Hepatitis: Chronic Hepatitis C讀者反饋




書目名稱Viral Hepatitis: Chronic Hepatitis C讀者反饋學科排名

助記

Laboratory and Molecular Diagnosis of Hepatitis C and Resistance Testing,stics as well. Here in this chapter, we elaborate the techniques used in the laboratory and molecular testing for the hepatitis C virus along with the resistance testing. The chapter focuses on the screening and confirmatory tests that are used in the diagnosis of HCV along with the indications for

推延

注意

脆弱吧

Treatment of Hepatitis C Virus-Infected Patients with Renal Failure,HCV infection is independently associated with the development of chronic kidney disease. The selection of the most appropriate regimen depends on genotype, presence or absence of cirrhosis, prior treatment history, and, in patients with renal failure, degree of renal impairment. Since HCV infection

Leaven

Treatment of Hepatitis C Virus in Special Populations (HBV Coinfection, Drug Users, and Prisoners),d in geographical areas where both infections have an intermediate or a high endemicity level and in special populations at high risk of acquiring both infections. Patients with dual-HBV/HCV infection more frequently develop liver cirrhosis and hepatocellular carcinoma (HCC) than those with a single

細絲

HIV/HCV Coinfection: Current Challenges,.It was previously observed that HIV/HCV-coinfected patients suffered from faster progression of liver fibrosis compared to HCV-mono-infected patients, resulting in increased rates of cirrhosis and decompensation of liver disease. However, over the past decade, the natural history of HIV/HCV coinfec

UTTER

Management of Interferon-Free Direct-Acting HCV Antiviral Therapy Failure,rhosis, liver failure, and hepatocellular carcinoma if remains untreated. The landscape of chronic hepatitis C treatment has evolved rapidly since 2011 with the arrivals of multiple combinations of direct-acting antiviral (DAA) therapies with the excellent sustained virological response, in the 90%.

被詛咒的人

博識

Extrahepatic Manifestations of Hepatitis C Virus Infection, because of the additional HCV-associated extrahepatic manifestations (EHMs) that occur. HCV infection is a global health problem, with 150–170 million people being chronically infected. It is estimated that about 350,000 patients die from HCV-related complications. However, the risks of mortality a